4Mazze RS, Strock E, Wesley D, et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther,2008,10 ( 3 ) : 149-159.
5Diabetes Control and Complications Trial Research Group:The elect of intensive treatment of diabetes on the development an d progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993,329(9) :977-986.
6Gerstein HC, Riddle MC, Kendall DM, et al. Glyeemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol,2007,99(12A) :34-43.
7Hirsch IB, Brownlee M. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care,2007,30( 1 ) : 186-187.
8Ceriello A, Esposito K,Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes, 2008,57 (5) : 1349-1354.
9Rodbard D. Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG)data for management of patients with diabetes. J Diabetes Sci Technol,2007,1 (1) :62-71.
10Frederico FR. Maia,Levimar Raraujo. Metabolic/glycose control accu- racy, effect and complications of the continuous glucose monitoring system in diabetic patients. Rev Assoc Med Bras, 2006, 152 (6) :1205.
1Donga E iVan Dijl~ M, Hoogma RPLM,et al. Insulin resistancein multiple tissues tissues in patients with type 1 diabetes mellitus onlong- term continuous subcutaneous insuin infusion therapy [ J ]. Diabetes Metab Res Rev,2013,29( 1 ) :33-38.
2Kentaro Y, Takahisa K, Shigeki O, et al. The Significance of Measuring Body Fat Percentage Determined by BioelectricalImpedance Analysis tor Detecting Subjects With Cardiovascular Disease Risk Factors [J].Circulation Journal, 2012,76 ( 9 ) : 2435- 2442.
3Weng J,Li Y, Xu W, et al. Effect of intensive insulin therapy onbeta- cell function and glycaemic control in patients with newlydiagnosed type 2 diabetes:a muhicentre randomised parallel - group trial[ J]. Lancet,2008,371 (9626) : 1753-1760.
